Signal #136216 · SEC 8-K

$CTKB SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CTKB filing catalyst

Why did $CTKB trigger an AI stock catalyst alert?

$CTKB triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.5/10). Headline: Cytek Biosciences Reports Q3 Revenue of $53.2M, Net Loss Widens to $(0.05) per Share. Key points: - Total Q3 revenue rose 2% year-over-year to $53.2 million. - Adjusted gross margin expanded to 61% compared to 55% in Q3 2025. - GAAP net loss widened to $(6.0)M, or $(0.05) per share, compared to $(5.4)M or $(0.04) per share in the prior-year period.

How did $CTKB stock react after the SEC filing?

After the SEC 8-K for $CTKB, observed market reaction: T0 price $5.88. Past moves do not guarantee future results.

Where can I get real-time $CTKB SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CTKB via Telegram and the VIP Web Terminal from €10/month.

$CTKB

$CTKB – Cytek Biosciences Reports Q3 Revenue of $53.2M, Net Loss Widens to $(0.05) per Share

Cytek Biosciences, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $CTKB

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-2.5 / 10)

Total Q3 revenue rose 2% year-over-year to $53.2 million.
Adjusted gross margin expanded to 61% compared to 55% in Q3 2025.
GAAP net loss widened to $(6.0)M, or $(0.05) per share, compared to $(5.4)M or $(0.04) per share in the prior-year period.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →